Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and the United States of America (USA). The aim of this
trial is to compare the effect on glycaemic control of liraglutide or exenatide when added to
subject's ongoing OAD (oral anti-diabetic drug) treatment of either metformin, sulphonylurea
or a combination of both in subjects with type 2 diabetes. Two trial periods: A 26 week
randomised, followed by a 52 week extension (14 + 38 weeks) where all subjects received
liraglutide + OAD after previous randomisation to either liraglutide or exenatide, both
combined with OAD treatment.